In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify marijuana being a Routine III drug. This rescheduling will understand that cannabis has legitimate clinical uses and may help open the door to research on other potential procedure utilizes. Shorter